Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma - Anatomical Variations, Mimickers, and Post-Intervention Changes

Overview

Journal Semin Ultrasound CT MR

Specialty Radiology

Date 2024 Nov 23

PMID 39580037

Authors

Enis C Yilmaz

Omer Tarik Esengur

David G Gelikman

Baris Turkbey

Affiliations

Soon will be listed here.

Abstract

Prostate magnetic resonance imaging (MRI) is an essential tool in the diagnostic pathway for prostate cancer. However, its accuracy can be confounded by a spectrum of noncancerous entities with similar radiological features, posing a challenge for definitive diagnosis. This review synthesizes current knowledge on the MRI phenotypes of both common and rare benign prostate conditions that may be mistaken for malignancy. The narrative encompasses anatomical variants, other neoplastic processes, inflammatory conditions, and alterations secondary to medical interventions. Furthermore, this review underscores the critical role of MRI quality in diagnostic accuracy and explores the emerging contributions of artificial intelligence in enhancing image interpretation.

References

Walker S, Turkbey B . Role of mpMRI in Benign Prostatic Hyperplasia Assessment and Treatment. Curr Urol Rep. 2020; 21(12):55. DOI: 10.1007/s11934-020-01005-x. View

Smolski M, Turo R, Whiteside S, Bromage S, Collins G . Prevalence of prostatic calcification subtypes and association with prostate cancer. Urology. 2014; 85(1):178-81. DOI: 10.1016/j.urology.2014.09.026. View

Rosenkrantz A, Ayoola A, Hoffman D, Khasgiwala A, Prabhu V, Smereka P . The Learning Curve in Prostate MRI Interpretation: Self-Directed Learning Versus Continual Reader Feedback. AJR Am J Roentgenol. 2016; 208(3):W92-W100. DOI: 10.2214/AJR.16.16876. View

Yilmaz E, Belue M, Turkbey B, Reinhold C, Choyke P . A Brief Review of Artificial Intelligence in Genitourinary Oncological Imaging. Can Assoc Radiol J. 2022; 74(3):534-547. DOI: 10.1177/08465371221135782. View

Li Y, Mongan J, Behr S, Sud S, Coakley F, Simko J . Beyond Prostate Adenocarcinoma: Expanding the Differential Diagnosis in Prostate Pathologic Conditions. Radiographics. 2016; 36(4):1055-75. DOI: 10.1148/rg.2016150226. View

Ahn H, Hwang S, Kim T, Lee H, Choe G, Hong S . Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasound. Prostate Cancer Prostatic Dis. 2022; 26(2):360-366. DOI: 10.1038/s41391-022-00531-8. View

Scheltema M, Chang J, van den Bos W, Bohm M, Delprado W, Gielchinsky I . Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation. Eur Urol Focus. 2017; 5(4):585-591. DOI: 10.1016/j.euf.2017.10.007. View

Sharif-Afshar A, Feng T, Koopman S, Nguyen C, Li Q, Shkolyar E . Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging. Can J Urol. 2015; 22(2):7698-702. View

Mertan F, Greer M, Borofsky S, Kabakus I, Merino M, Wood B . Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer. Top Magn Reson Imaging. 2016; 25(3):139-47. PMC: 5462597. DOI: 10.1097/RMR.0000000000000088. View

10.

Muglia V, Saber G, Maggioni Jr G, Monteiro A . MRI findings of prostate stromal tumour of uncertain malignant potential: a case report. Br J Radiol. 2011; 84(1006):e194-6. PMC: 3473770. DOI: 10.1259/bjr/67699443. View

11.

Potretzke T, Froemming A, Gupta R . Post-treatment prostate MRI. Abdom Radiol (NY). 2019; 45(7):2184-2197. DOI: 10.1007/s00261-019-02348-x. View

12.

Hansford B, Karademir I, Peng Y, Jiang Y, Karczmar G, Thomas S . Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol. 2014; 21(5):569-77. DOI: 10.1016/j.acra.2014.01.013. View

13.

Kitzing Y, Prando A, Varol C, Karczmar G, Maclean F, Oto A . Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation. Radiographics. 2015; 36(1):162-75. PMC: 5496681. DOI: 10.1148/rg.2016150030. View

14.

Han C, Zhu L, Liu X, Ma S, Liu Y, Wang X . Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information. Insights Imaging. 2021; 12(1):79. PMC: 8208342. DOI: 10.1186/s13244-021-01024-3. View

15.

Joyce E, Kavanagh J, Sheehy N, Beddy P, OKeeffe S . Imaging features of extrapulmonary small cell carcinoma. Clin Radiol. 2013; 68(9):953-61. DOI: 10.1016/j.crad.2013.04.006. View

16.

Kulik M, Nedelcu C, Martin F, Lebdai S, Rousselet M, Azzouzi A . Post-treatment MRI aspects of photodynamic therapy for prostate cancer. Insights Imaging. 2014; 5(6):697-713. PMC: 4263801. DOI: 10.1007/s13244-014-0359-8. View

17.

Schieda N, Coffey N, Gulavita P, Al-Dandan O, Shabana W, Flood T . Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI). Eur Radiol. 2014; 24(6):1349-56. DOI: 10.1007/s00330-014-3150-9. View

18.

Lin Y, Belue M, Yilmaz E, Harmon S, An J, Law Y . Deep Learning-Based T2-Weighted MR Image Quality Assessment and Its Impact on Prostate Cancer Detection Rates. J Magn Reson Imaging. 2023; 59(6):2215-2223. PMC: 11001787. DOI: 10.1002/jmri.29031. View

19.

Frenk N, Baroni R, Carnevale F, Goncalves O, Antunes A, Srougi M . MRI findings after prostatic artery embolization for treatment of benign hyperplasia. AJR Am J Roentgenol. 2014; 203(4):813-21. DOI: 10.2214/AJR.13.11692. View

20.

Rosenkrantz A, Scionti S, Mendrinos S, Taneja S . Role of MRI in minimally invasive focal ablative therapy for prostate cancer. AJR Am J Roentgenol. 2011; 197(1):W90-6. DOI: 10.2214/AJR.10.5946. View